Company / SG&A Expense
ClearPoint Neuro, Inc. SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$16.5M
FY2025
5-year range
$8.0M / $16.5M
FY2021-FY2025
Trend
+40.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A Expense has fluctuated over the past 10 years, ranging from $4M in FY2017 to $16M in FY2025.
Based on SEC 10-K filings.
$16M in FY2025 with a 5-year CAGR of +25.6%.
Increased from $12M to $16M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +19.7%
- 5-Year CAGR
- +25.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +25.6%, indicating consistent growth.
- In FY2025, sg&a expense increased 40.3% year-over-year.
- Lowest sg&a expense in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -1.71 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $16.5M | +40.3% |
| FY2024 | $11.8M | +0.0% |
| FY2023 | $11.8M | +22.3% |
| FY2022 | $9.6M | +20.2% |
| FY2021 | $8.0M | +51.8% |
| FY2020 | $5.3M | +22.5% |
| FY2019 | $4.3M | -0.5% |
| FY2018 | $4.3M | +6.9% |
| FY2017 | $4.0M | -3.4% |
| FY2016 | $4.2M | -49.9% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026